Tripelennamine hydrochloride
CAS No. 154-69-8
Tripelennamine hydrochloride ( Pyribenzamine hydrochloride )
Catalog No. M12195 CAS No. 154-69-8
A first-generation antihistamine that acts primarily as H1 receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 30 | In Stock |
|
50MG | 42 | In Stock |
|
100MG | 61 | In Stock |
|
200MG | 92 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTripelennamine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA first-generation antihistamine that acts primarily as H1 receptor antagonist.
-
DescriptionA first-generation antihistamine that acts primarily as H1 receptor antagonist; has little or no anticholinergic activity, also acts as a weak serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).Asthma Approved
-
SynonymsPyribenzamine hydrochloride
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1receptor
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number154-69-8
-
Formula Weight291.82
-
Molecular FormulaC16H22ClN3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33 mg/mL
-
SMILESCl.CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1
-
Chemical Name1,2-Ethanediamine, N1,N1-dimethyl-N2-(phenylmethyl)-N2-2-pyridinyl-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Oishi R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):140-4.
2. Sato T, et al. Jpn J Pharmacol. 1996 May;71(1):81-4.
3. Yeh SY, et al. Synapse. 1999 Sep 1;33(3):207-17.
2. Sato T, et al. Jpn J Pharmacol. 1996 May;71(1):81-4.
3. Yeh SY, et al. Synapse. 1999 Sep 1;33(3):207-17.
molnova catalog
related products
-
Loratadine
A tricyclic antihistamine that acts as a selective inverse agonist of peripheral histamine H1-receptors.
-
Noctone
Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production.Ranitidine (Zantac) is a histamine H2-receptor antagonist with IC50 of 3.3 ± 1.4 uM.
-
Betahistine mesylate
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease.